Home

Insights

Bal Pharma Ltd dividend

Bal Pharma Ltd dividend

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.8 K

stocks traded

Image

Bal Pharma Ltd

NSE: BALPHARMA

DPS

1

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Bal Pharma Ltd is ₹ 1 as of 2023 .a1#The Dividend Payout of Bal Pharma Ltd changed from 20.96 % on March 2019 to 25.6 % on March 2023 . This represents a CAGR of 4.08% over 5 years. a1#The Latest Trading Price of Bal Pharma Ltd is ₹ 102.91 as of 18 May 15:30 .a1#The Market Cap of Bal Pharma Ltd changed from ₹ 99.92 crore on March 2019 to ₹ 105.01 crore on March 2023 . This represents a CAGR of 1.00% over 5 years. a1#The Revenue of Bal Pharma Ltd changed from ₹ 70.08 crore to ₹ 81.76 crore over 7 quarters. This represents a CAGR of 9.21% a1#The EBITDA of Bal Pharma Ltd changed from ₹ 5.28 crore to ₹ 7.89 crore over 7 quarters. This represents a CAGR of 25.80% a1#The Net Profit of Bal Pharma Ltd changed from ₹ 0.28 crore to ₹ 0.85 crore over 7 quarters. This represents a CAGR of 88.62% a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

Share Price Vs Dividend Yield

swot
swot

Fundamental Metrics

Market Cap

162 Cr

EPS

2.2

P/E Ratio (TTM) *

46.2

P/B Ratio (TTM) *

2.6

DTE *

2.2

ROE *

5.1

ROCE *

9.6

Dividend Yield *

1.49

DPS *

1

Dividend Payout *

25.6

Ann.Dividend % *

10

* All values are consolidated

* All values are consolidated

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1921
Mar '200
Mar '2116
Mar '2217
Mar '2326

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Bal Pharma Ltd

NSE: BALPHARMA

PRICE

102.91

-0.30(-0.29%)

stock direction

Last updated : 18 May 15:30

SWOT Analysis Of Bal Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

Dividend Overview for Bal Pharma Ltd

  • Bal Pharma Ltd, boasts of a market capitalization of Rs 163 Cr., with a share price of Rs 102.91 as of 18 May 15:30. While all stocks don't consistently pay dividends, Bal Pharma Ltd rewarded its shareholders, distributing 25.6 % for the full year.
  • In the year ending 2022, Bal Pharma Ltd declared a dividend of Rs 1, resulting in a dividend yield of 0.9% Assessing its dividend-paying capacity and valuation is crucial to determine its suitability as a dividend stock.
  • During the year ending 2023, Bal Pharma Ltd recorded revenues of Rs 327 Cr, with a trailing EBITDA Margin of 9.4% and net-profit of Rs 4 Cr

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '19100
Mar '2046
Mar '2180
Mar '22160
Mar '23105

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '2270
Sep '2275
Dec '2277
Mar '2283
Jun '2371
Sep '2393
Dec '2382

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '225
Sep '226
Dec '227
Mar '228
Jun '237
Sep '238
Dec '238

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '220
Sep '220
Dec '221
Mar '222
Jun '230
Sep '231
Dec '231

* All values are a in crore

About Bal Pharma Ltd

About Bal Pharma Ltd

    Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The company's product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM. The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named 'SERVETUS' has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002. The commercial production of Formulation Plant in Uttarakhand started from 1st January, 2009. The Company floated Lifezen Healthcare Pvt Ltd during the year 2014-15 as its subsidiary. It ventured into heath care sector through its subsidiary i.e. Balance Clinics LLP. In 2016-17, it commenced its project on construction of an fully integrated API unit with an annual production capacity of 270 metric tonnes of assorted API products including Gliclazide, Ebastine, Amiloride HCL, Benzydamine HCL, Pregablin etc, located at Gauribidanur near Bangalore with an estimated investment of Rs 45 Crores. In 2017-18, the Company acquired 100% stake and management control of Golden Drugs Private Ltd, an Udaipur, Rajasthan involved in the manufacture of bulk drugs and intermediates costing Rs 14 Crores. It earmarked Rs. 36 Cr. for setting up of an bulk drug's manufacturing unit at Yadgir District , Karnataka in year 2022-23. It launched Sitagliptin (a DPP-4 Inhibitor) in the plain form, and as a combination with Metformin under the brand names SITABEND & SITABEND-M, respectively in 2023.

Bal Pharma Ltd News Hub

News

Bal Pharma declare Quarterly Result

Bal Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024. Po...

Read more

30 Apr 2024 12:51

News

Bal Pharma to table results

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 February 202...

Read more

25 Jan 2024 17:14

News

Bal Pharma to conduct EGM

Bal Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Nov 2023 10:51

News

Bal Pharma to table results

Bal Pharma will hold a meeting of the Board of Directors of the Company on 8 November 2023...

Read more

21 Oct 2023 17:06

News

Bal Pharma to hold EGM

Bal Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

04 Sep 2023 10:22

News

Bal Pharma to convene AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

16 Aug 2023 16:58

FAQs for dividends of Bal Pharma Ltd

What is the current market price of Bal Pharma Ltd Ltd as of May 18, 2024?

The current market price of Bal Pharma Ltd Ltd stands at 102.9 per share.

What dividend did Bal Pharma Ltd declare in the last fiscal year?

In the last fiscal year, Bal Pharma Ltd declared a dividend totaling ₹1.0.

What is the most recent dividend declared by Bal Pharma Ltd?

Bal Pharma Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Bal Pharma Ltd declared dividends in the current fiscal year

Bal Pharma Ltd has declared dividends 3 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Bal Pharma Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Bal Pharma Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199